Stem Cell Activation by NutraVivo™ Dietary Supplements

Stem cell therapies and regenerative medicine are new and upcoming medical treatments. Stem cells are undifferentiated cells that reside throughout the body that give rise to other kinds of cell types (neurons, heart cells, bone cells, etc.) Recently these cells have been studied for anti-aging effects, reversing blindness, regenerating cartilage, etc. Bone marrow derived stem [...]

2018-05-07T18:00:51+00:00 March 27th, 2018|

Anti-Aging Stem Cell Therapy Improves Quality of Life

Scientists at the University of Miami Miller School of Medicine completed a clinical trial showing safety and efficacy of stem cell therapy in treatment of frailty, a common aging symptom caused by reduced function of stem cells and inflammation.1 Stem cells in the body serve several functions including repair and regeneration of damaged tissues, production [...]

2018-03-06T00:43:54+00:00 October 31st, 2017|

Recent Advances in Stem Cell Therapy of Stroke

An interim report of a clinical trial of intracerebral injection of stem cells adds to a growing body of evidence supporting safety and efficacy of stem cell therapy for stroke.  A clinical team led by Dr. Gary Steinberg at Stanford University Medical Center reported results from 16 patients who received stereotactic injections into damaged brain [...]

2018-03-13T01:35:09+00:00 June 13th, 2016|

Vitro Biopharma Advances Stem Cell Activation Therapy for Concussion

Golden, Colorado—December 29, 2015 —Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced new developments of its stem cell activation therapy for concussion.  Dr. Omula’s research tying repetitive concussion to chronic traumatic encephalopathy is chronicled in the recently released movie, “Concussion.”  Vitro Biopharma is a leader in the field of stem cell activation therapy now [...]

2018-05-07T18:00:52+00:00 January 12th, 2016|

Vitro Biopharma Launches New Bioanalytical Services and Novel Stem Cell-derived Renal & Neural Cells

Golden, Colorado—September  22, 2015 —Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced expansion of its product/service offerings to include biomarker profiling services and stem cell derived neuronal and renal cells. Vitro Biopharma’s new services include simultaneous determination of several molecules through multi-plexed assays.  The cells of our bodies communicate with each other through the [...]

2018-05-07T18:00:52+00:00 September 25th, 2015|

Vitro Biopharma Announces Advancement of its Traumatic Brain Injury Clinical Trial & a Favorable Ruling from the FDA

Golden, Colorado—September 2, 2015 —Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced advances in clinical applications of its products and a favorable ruling by the FDA regarding this trial.  The Company’s phase I clinical trial consists of combining two previously FDA-approved drugs in a novel manner to treat TBI including concussion by regeneration of [...]

2018-05-07T18:00:52+00:00 September 3rd, 2015|

Stem Cell Therapy of Stroke: Current Research Support and Clinical Studies

Adult stem cell therapy is a common FDA-approved procedure for treatment of blood disorders including leukemia, lymphoma and autoimmune diseases.  Cell therapy using other types of adult stem cells including mesenchymal stem cells (MSCs), neural stem cells (NSCs) and muscle stem cells (Satellite cells) is supported by research findings and proof-of-principle clinical trials but this [...]

2018-05-07T18:00:53+00:00 February 17th, 2015|

Alternatives to Stem Cell Transplants Supported by Key Medical Breakthroughs of 2014

Golden, Colorado—January 13, 2015 —Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma, announced the growing scientific support for use of stem cells that reside within the body for therapeutic and performance enhancement.  A key medical advance of 2014 was research published by scientists at Stanford University and Harvard University regarding mechanisms underlying “parabiosis”, the well-known [...]

2018-05-07T18:00:53+00:00 January 13th, 2015|

Efficacy of Stem Cell Therapy for Stroke Demonstrated in Landmark Study using Vitro Biopharma Stem Cells & Media

Golden, Colorado—September 9, 2014—Vitro Diagnostics, Inc. (OTCQB: VODG), dba Vitro Biopharma announced the publication of a research study using its stem cells to treat an animal model of stroke.  University of Illinois College of Medicine at Peoria (UICOMP) researchers, led by Dr. Krishna Kumar Veeravalli recently published a study showing a prominent reduction in brain [...]

2018-05-07T18:00:53+00:00 September 9th, 2014|